Interleukin-10 polymorphisms in Spanish Multiple Sclerosis patients

Bell, 1996, Multiple loci for multiple sclerosis, Nat. Genet., 13, 377, 10.1038/ng0896-377 Cavet, 1999, Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associated with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants, Blood, 94, 3941, 10.1182/blood.V94.11.3941 Crawley, 1999, Polymorphic haplotypes of the interleukin-10 5′ flanking region determine variable interleukin-10 transcription, and are associated with particular phenotypes of juvenile rheumatoid arthritis, Arthritis Rheum., 42, 1101, 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y Cua, 2001, Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis, J. Immunol., 166, 602, 10.4049/jimmunol.166.1.602 Ebers, 1996, A full genome search in multiple sclerosis, Nat. Genet., 13, 472, 10.1038/ng0896-472 Eskdale, 1995, A polymorphic dinucleotide repeat in the human IL-10 promoter, Immunogenetics, 42, 444, 10.1007/BF00179416 Eskdale, 1996, A second polymorphic dinucleotide repeat in the 5′ flanking region of the human IL10 gene, Immunogenetics, 45, 82, 10.1007/s002510050174 Eskdale, 1997, Mapping of the human IL10 gene and further characterization of the 5′ flanking sequence, Immunogenetics, 46, 120, 10.1007/s002510050250 Eskdale, 1997, Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus, Tissue Antigens, 49, 635, 10.1111/j.1399-0039.1997.tb02812.x Eskdale, 1998, Interleukin 10 secretion in relation to human IL-10 locus haplotypes, Proc. Natl. Acad. Sci. U. S. A., 95, 9465, 10.1073/pnas.95.16.9465 Eskdale, 1999, Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus, Genes Immun., 1, 151, 10.1038/sj.gene.6363656 Gayo, 2000, Long-term effect of IFNbeta1b treatment on the spontaneous and induced expression of IL-10 and TGFbeta1 in MS patients, J. Neurol. Sci., 179, 43, 10.1016/S0022-510X(00)00369-5 Gibson, 2001, Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus, J. Immunol., 166, 3915, 10.4049/jimmunol.166.6.3915 Haines, 1996, A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group, Nat. Genet., 13, 469, 10.1038/ng0896-469 He, 1998, Linkage and association analysis of genes encoding cytokines and myelin proteins in multiple sclerosis, J. Neuroimmunol., 86, 13, 10.1016/S0165-5728(98)00003-4 Karp, 2000, Interferon beta in multiple sclerosis: is IL-12 suppression the key?, Immunol. Today, 21, 24, 10.1016/S0167-5699(99)01541-8 Karp, 2001, Interferon-beta in multiple sclerosis: altering the balance of interleukin-12 and interleukin-10?, Curr. Opin. Neurol., 14, 361, 10.1097/00019052-200106000-00016 Kuokkanen, 1996, A putative vulnerability locus to multiple sclerosis maps to 5p14–p12 in a region syntenic to the murine locus Eae2, Nat. Genet., 13, 477, 10.1038/ng0896-477 Martinez, 2001, Primary association of a MICA allele with protection against rheumatoid arthritis, Arthritis Rheum., 44, 1261, 10.1002/1529-0131(200106)44:6<1261::AID-ART217>3.0.CO;2-L Maurer, 2000, Genetic variation at position-1082 of the interleukin 10 (IL-10) promotor and the outcome of multiple sclerosis, J. Neuroimmunol., 104, 98, 10.1016/S0165-5728(99)00256-8 McDonnell, 2000, An evaluation of interleukin genes fails to identify clear susceptibility loci for multiple sclerosis, J. Neurol. Sci., 176, 4, 10.1016/S0022-510X(00)00291-4 Mullighan, 1999, Variation in immunoregulatory genes determines the clinical phenotype of common variable immunodeficiency, Genes Immun., 1, 137, 10.1038/sj.gene.6363653 Noseworthy, 1999, Progress in determining the causes and treatment of multiple sclerosis, Nature, 399, A40, 10.1038/399a040 Pickard, 1999, Interleukin-10 (IL-10) promoter polymorphisms and multiple sclerosis, J. Neuroimmunol., 101, 207, 10.1016/S0165-5728(99)00146-0 Sawcer, 1996, A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22, Nat. Genet., 13, 464, 10.1038/ng0896-464 Turner, 1997, Cytokine gene polymorphism and heart transplant rejection, Transplantation, 64, 776, 10.1097/00007890-199709150-00021 Turner, 1997, An investigation of polymorphism in the interleukin-10 gene promoter, Eur. J. Immunogenet., 24, 1, 10.1111/j.1365-2370.1997.tb00001.x Zang, 2000, Immunoregulation and blocking antibodies induced by interferon beta treatment in MS, Neurology, 55, 397, 10.1212/WNL.55.3.397